(Q86014195)
Statements
Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study (English)
P Rich
D Thaci
J-P Ortonne
R E Schopf
A Morita
K Roseau
E Harfst
A Guettner
M Machacek
C Papavassilis
1 February 2013